These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8230462)

  • 1. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.
    Klingmüller U; Schaller H
    J Virol; 1993 Dec; 67(12):7414-22. PubMed ID: 8230462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.
    Pugh JC; Di Q; Mason WS; Simmons H
    J Virol; 1995 Aug; 69(8):4814-22. PubMed ID: 7609048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180.
    Urban S; Breiner KM; Fehler F; Klingmüller U; Schaller H
    J Virol; 1998 Oct; 72(10):8089-97. PubMed ID: 9733849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic mixing of rodent but not avian hepadnavirus surface proteins into human hepatitis B virus particles.
    Gerhardt E; Bruss V
    J Virol; 1995 Feb; 69(2):1201-8. PubMed ID: 7815496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection.
    Li J; Tong S; Lee HB; Perdigoto AL; Spangenberg HC; Wands JR
    J Virol; 2004 Feb; 78(4):1873-81. PubMed ID: 14747552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor.
    Li JS; Tong SP; Wands JR
    J Virol; 1996 Sep; 70(9):6029-35. PubMed ID: 8709225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral and cellular determinants involved in hepadnaviral entry.
    Glebe D; Urban S
    World J Gastroenterol; 2007 Jan; 13(1):22-38. PubMed ID: 17206752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.
    Lambert V; Fernholz D; Sprengel R; Fourel I; Deléage G; Wildner G; Peyret C; Trépo C; Cova L; Will H
    J Virol; 1990 Mar; 64(3):1290-7. PubMed ID: 1689393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell surface protein that binds avian hepatitis B virus particles.
    Kuroki K; Cheung R; Marion PL; Ganem D
    J Virol; 1994 Apr; 68(4):2091-6. PubMed ID: 8138993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.
    Dallmeier K; Schultz U; Nassal M
    PLoS Pathog; 2008 Dec; 4(12):e1000230. PubMed ID: 19057662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
    Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection.
    Tong S; Li J; Wands JR
    J Virol; 1995 Nov; 69(11):7106-12. PubMed ID: 7474130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological efficacy and signal transduction through STAT proteins of recombinant duck interferon in duck hepatitis B virus infection.
    Heuss LT; Heim MH; Schultz U; Wissmann D; Offensperger WB; Staeheli P; Blum HE
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():2007-12. PubMed ID: 9714251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
    Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
    Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of DNA vaccines against duck hepatitis B virus infection.
    Triyatni M; Jilbert AR; Qiao M; Miller DS; Burrell CJ
    J Virol; 1998 Jan; 72(1):84-94. PubMed ID: 9420203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein.
    Urban S; Gripon P
    J Virol; 2002 Feb; 76(4):1986-90. PubMed ID: 11799193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle.
    Borel C; Sunyach C; Hantz O; Trepo C; Kay A
    Virology; 1998 Mar; 242(1):90-8. PubMed ID: 9501048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to a 55-kilodalton protein present in duck liver inhibit infection of primary duck hepatocytes with duck hepatitis B virus.
    Guo JT; Pugh JC
    J Virol; 1997 Jun; 71(6):4829-31. PubMed ID: 9151880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of infectious and defective cloned avian hepadnavirus genomes.
    Wildner G; Fernholz D; Sprengel R; Schneider R; Will H
    Virology; 1991 Nov; 185(1):345-53. PubMed ID: 1926780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus.
    Meier P; Scougall CA; Will H; Burrell CJ; Jilbert AR
    Virology; 2003 Dec; 317(2):291-8. PubMed ID: 14698667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.